Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene Appoints Harvard Professor to Scientific Board

NEW YORK, May 29 – AlphaGene said Tuesday it had appointed Robert Brown, a neurology professor at Harvard Medical School, as a member of its scientific advisory board.

Brown will work with AlphaGene of Woburn, Mass., to find novel genes associated with a recessive form of Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease.

Brown, who is also director of the Day Neuromuscular Research Laboratory at Massachusetts General Hospital, helped to define mutations in the gene encoding SOD1 as one cause of hereditary ALS.

“The use of our proprietary microarrays to study differential gene expression will provide, what we hope will be, significant insights to defining and developing therapeutic targets with Dr. Brown's assistance", Donald McCarren, CEO of AlphaGene, said in a statement.

AlphaGene is a privately held genomics that focuses on differential gene expression in degenerative neurological diseases such as Parkinson’s and Alzheimer’s.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.